Is an active hospital microbiology laboratory cost-effective in a resource-limited setting? - a case study from Timor-Leste.
Lim, C.; Swe, M. M. M.; Devine, A.; Oakley, T.; Champlin, K.; Oo, P. S.; Sarmento, N.; Barreto, I. D. C.; Givney, R. C.; Yan, J.; Francis, J. R.; Cooper, B. S.
Show abstract
Maintaining an active hospital microbiology laboratory allows definitive antibiotic treatment for bacterial infections to be given in a timely manner. This would be expected to improve patient outcomes and shorten length of hospital stay. However, many hospitals in low- and middle-income countries lack access to microbiology services, and the cost-effectiveness of an active microbiology service is unknown. We constructed a decision tree and performed a cost-effectiveness model analysis to determine whether maintaining an active microbiology laboratory service would be cost-effective in Timor-Leste, a lower middle-income country. The analysis was informed by local microbiology data, local patient treatment costs, results of an expert elicitation exercise and data from literature reviews. The results indicate that there is a high probability that maintaining an active microbiology laboratory is a cost-effective intervention that would both improve patient outcomes and reduce net costs (due to reduced intensive care admissions and potential costs of resistant infections) compared to no microbiological testing, especially for the hospitalised paediatric patients with suspected primary bacteraemia. This remained true under various one-way sensitivity analyses, including when accuracy of microbiological testing is low, prevalence of bacterial infection among patients with suspected bloodstream infection was high, and prevalence of antibiotic resistance was high.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Cost-effectiveness of intensive care for hospitalized Covid-19 patients: experience from South Africa 93%
- Cost-effectiveness of whole area testing of asymptomatic SARS-CoV-2 infections in Merthyr Tydfil, 2020: A Modelling and economic analysis 93%
- Predictive accuracy of computer-aided versions of the on-admission National Early Warning Score in estimating the risk of COVID-19 for unplanned admission to hospital: a retrospective development and validation study 92%
Similar papers in this journal
- Criteria to Achieve Safe Antimicrobial Intravenous-to-Oral Switch in Hospitalised Adult Populations: A Systematic Rapid Review 93%
- Aortic stenosis post-COVID-19: A mathematical model on waiting lists and mortality 91%
- Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: systematic review and meta-analysis 91%
Similar papers in this journal
- Estimating the cost of antibiotic use on future collateral resistance: a retrospective comparison of cefuroxime versus cefazolin and amoxicillin/clavulanate 94%
- Mortality risks associated with empirical antibiotic activity in E. coli bacteraemia: an analysis of electronic health records 93%
- Antibiotics and hospital-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update 93%
Similar papers in this journal
- A Sepsis Treatment Algorithm to Improve Early Antibiotic De-escalation While Maintaining Adequacy of Coverage (Early-IDEAS): A Prospective Observational Study 94%
- Reduced turnaround times through multi-sectoral collaboration during the first surge of SARS-CoV-2 in Louisiana, March-April 2020 92%
- LMIC-PRIEST: Derivation and validation of a clinical severity score for acutely ill adults with suspected COVID-19 in a middle-income setting 92%
Similar papers in this journal
- Clinical Benefits and Budget Impact of Lenzilumab plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with COVID-19 in the United States from the Hospital Perspective 93%
- Reflex single-gene non-invasive prenatal testing significantly increases the cost-effectiveness of carrier screening 91%
- Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.